.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Conventional deep brain stimulation delivers stimulation using relatively fixed settings, even though Parkinson symptoms and neural activity fluctuate throughout the day. This blinded randomized feasibility trial tested chronic adaptive deep brain stimulation, in which stimulation was adjusted according to patient-specific neural signals. Four people with Parkinson disease received both adaptive and conventional stimulation during crossover testing. The investigators identified neural activity patterns associated with dopaminergic state and residual motor symptoms and used these signals to drive adaptive stimulation. Adaptive DBS improved motor symptoms and quality of life compared with clinically optimised continuous stimulation in this small pilot study. The study is important because it demonstrates a possible path toward truly personalised neuromodulation, but the sample was very small and the findings are not yet sufficient for routine clinical adoption. For HCPs, the main message is translational: future DBS systems may respond dynamically to the patient's neural state rather than relying on fixed programming. Larger trials are needed to establish durability, generalisability, safety and the best biomarkers for control. The work aligns closely with IANCON's interest in advanced neuromodulation and data-driven movement-disorder care.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Conventional deep brain stimulation delivers stimulation using relatively fixed settings, even though Parkinson symptoms and neural activity fluctuate throughout the day. This blinded randomized feasibility trial tested chronic adaptive deep brain stimulation, in which stimulation was adjusted according to patient-specific neural signals. Four people with Parkinson disease received both adaptive and conventional stimulation during crossover testing. The investigators identified neural activity patterns associated with dopaminergic state and residual motor symptoms and used these signals to drive adaptive stimulation. Adaptive DBS improved motor symptoms and quality of life compared with clinically optimised continuous stimulation in this small pilot study. The study is important because it demonstrates a possible path toward truly personalised neuromodulation, but the sample was very small and the findings are not yet sufficient for routine clinical adoption. For HCPs, the main message is translational: future DBS systems may respond dynamically to the patient's neural state rather than relying on fixed programming. Larger trials are needed to establish durability, generalisability, safety and the best biomarkers for control. The work aligns closely with IANCON's interest in advanced neuromodulation and data-driven movement-disorder care.
4 weeks back
Explore the therapeutic promise of TLR7 and TLR8 inhibitors in managing systemic lupus erythematosus and monogenic autoimmune diseases. Learn how targeting endolysosomal single-stranded RNA sensing and regulatory checkpoints like UNC93B1 and PLD4 offers precision treatment without broad immunosuppression.
2 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
2 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
2 days back
